共 55 条
[1]
Ozaki A(2012)Quality of life in patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time: comparison between patients on psychostimulants, drug-naïve patients and the general Japanese population Sleep Med 13 200-206
[2]
Inoue Y(2017)Update on the treatment of narcolepsy: clinical efficacy of pitolisant Nat Sci Sleep 9 127-133
[3]
Hayashida K(2008)The histamine H3 receptor: an attractive target for the treatment of cognitive disorders Br J Pharmacol 154 1166-1181
[4]
Calik MW(2011)The evolution of histamine H Curr Top Med Chem 11 648-660
[5]
Esbenshade TA(2019) antagonists/inverse agonists Ther Adv Neurol Disord 12 1756286419875622-285
[6]
Browman KE(2020)Recent advances in treatment for narcolepsy J Pharmacol Exp Ther 375 276-255
[7]
Bitner RS(2019)A novel potent and selective histamine H3 receptor antagonist enerisant: in vitro profiles, in vivo receptor occupancy, and wake-promoting and procognitive effects in rodents Neuropharmacology 144 244-10
[8]
Lebois EP(2021)Drug-receptor kinetics and sigma-1 receptor affinity differentiate clinically evaluated histamine H3 receptor antagonists Xenobiotica. 28 1-97
[9]
Jones CK(2007)Drug–drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist Jpn J Sleep Med (Suiminiryo) 1 85-562
[10]
Lindsley CW(1997)Efficacy and safety of treatment with modafinil in Japanese patients with narcolepsy: results from double blind placebo-controlled study Electroencephalogr Clin Neurophysiol 103 554-1108